Cadrenal Therapeutics (CVKD) Assets (2022 - 2026)
Cadrenal Therapeutics (CVKD) posted Assets of $2.9 million for Q1 2026, down 33.85% sequentially from $4.3 million in Q4 2025, and down 64.01% YoY from $8.0 million in Q1 2025.
Cadrenal Therapeutics (CVKD) Assets (2022 - 2026) Analysis & Trends
Cadrenal Therapeutics has reported Assets for 5 years, with the latest figure at $2.9 million in Q1 2026.
- Quarterly Assets fell 64.01% year-over-year to $2.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.9 million (down 64.01% YoY) and the FY2025 annual result came in at $4.3 million, down 57.26% from the prior year.
- Assets slipped to $2.9 million in Q1 2026 per CVKD's latest filing, from $4.3 million in the prior quarter.
- Over five years, Assets peaked at $10.1 million in Q4 2024 and troughed at $778174.0 in Q4 2022.
- A 5-year average of $5.7 million and a median of $5.1 million in 2024 frame the typical range for Assets.
- The sharpest annual moves came in 2023 and 2026: Assets jumped 994.77% in 2023, then plunged 64.01% in 2026.
- Over 5 years, Assets stood at $778174.0 in 2022, then surged by 994.77% to $8.5 million in 2023, then gained by 18.83% to $10.1 million in 2024, then plunged by 57.26% to $4.3 million in 2025, then plunged by 33.85% to $2.9 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $2.9 million, $4.3 million, and $4.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | Cadrenal Therapeutics | 4.59 Mn | 2.19 Mn | - | 5.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.59 Mn |
| Mar 31, 2026 | 2.86 Mn |
| Dec 31, 2025 | 4.33 Mn |
| Sep 30, 2025 | 4.09 Mn |
| Jun 30, 2025 | 5.98 Mn |
| Mar 31, 2025 | 7.95 Mn |
| Dec 31, 2024 | 10.12 Mn |
| Sep 30, 2024 | 4.68 Mn |
| Jun 30, 2024 | 5.46 Mn |
| Mar 31, 2024 | 7.05 Mn |
| Dec 31, 2023 | 8.52 Mn |
| Sep 30, 2023 | 9.31 Mn |
| Jun 30, 2023 | 3.56 Mn |
| Mar 31, 2023 | 4.48 Mn |
| Dec 31, 2022 | 778,174.00 |